These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates. Ishii Y, Eto M, Mano Y, Tateda K, Yamaguchi K. Antimicrob Agents Chemother; 2010 Sep; 54(9):3625-9. PubMed ID: 20606062 [Abstract] [Full Text] [Related]
5. IMP-51, a novel IMP-type metallo-β-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate. Tada T, Nhung PH, Miyoshi-Akiyama T, Shimada K, Phuong DM, Anh NQ, Ohmagari N, Kirikae T. Antimicrob Agents Chemother; 2015 Nov; 59(11):7090-3. PubMed ID: 26282421 [Abstract] [Full Text] [Related]
6. Carbapenem-resistant Pseudomonas aeruginosa in malaysia producing IMP-7 beta-lactamase. Ho SE, Subramaniam G, Palasubramaniam S, Navaratnam P. Antimicrob Agents Chemother; 2002 Oct; 46(10):3286-7. PubMed ID: 12234862 [Abstract] [Full Text] [Related]
7. Carbapenem derivatives as potential inhibitors of various beta-lactamases, including class B metallo-beta-lactamases. Nagano R, Adachi Y, Imamura H, Yamada K, Hashizume T, Morishima H. Antimicrob Agents Chemother; 1999 Oct; 43(10):2497-503. PubMed ID: 10508031 [Abstract] [Full Text] [Related]
8. In vitro antibacterial activity and mechanism of action of J-111,225, a novel 1beta-methylcarbapenem, against transferable IMP-1 metallo-beta-lactamase producers. Nagano R, Adachi Y, Hashizume T, Morishima H. J Antimicrob Chemother; 2000 Mar; 45(3):271-6. PubMed ID: 10702544 [Abstract] [Full Text] [Related]
9. Postantibiotic and post-beta-lactamase inhibitor effect of carbapenems combined with EDTA against Pseudomonas aeruginosa strains producing VIM-metallo beta-lactamases. Bedenić B, Vranes J, Sviben M, Beader N, Kalenić S. Chemotherapy; 2008 Mar; 54(3):188-93. PubMed ID: 18560225 [Abstract] [Full Text] [Related]
10. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea. Cho HH, Kwon GC, Kim S, Koo SH. J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063 [Abstract] [Full Text] [Related]
11. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia. Ohlasova D, Kmet V, Niks M. Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230 [No Abstract] [Full Text] [Related]
12. Effect of sodium mercaptoacetic acid on different antimicrobial disks in the sodium mercaptoacetic acid double disk synergy test for detection of IMP-1 metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in Japan. Sakanashi D, Miyazaki N, Kawamoto Y, Ohno T, Yamada A, Koita I, Miyajima S, Suematsu H, Hagihara M, Asai N, Koizumi Y, Yamagishi Y, Mikamo H. J Infect Chemother; 2019 Jan; 25(1):75-77. PubMed ID: 30100401 [Abstract] [Full Text] [Related]
13. Carbapenem-based prodrugs. Design, synthesis, and biological evaluation of carbapenems. Hakimelahi GH, Moosavi-Movahedi AA, Saboury AA, Osetrov V, Khodarahmi GA, Shia KS. Eur J Med Chem; 2005 Apr; 40(4):339-49. PubMed ID: 15804533 [Abstract] [Full Text] [Related]
14. In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa. Yamada K, Yanagihara K, Kaku N, Harada Y, Migiyama Y, Nagaoka K, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Hasegawa H, Yasuoka A, Kohno S. Int J Antimicrob Agents; 2013 Sep; 42(3):238-43. PubMed ID: 23891525 [Abstract] [Full Text] [Related]
15. Description of IMP-31, a novel metallo-β-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany. Pfennigwerth N, Geis G, Gatermann SG, Kaase M. J Antimicrob Chemother; 2015 Jul; 70(7):1973-80. PubMed ID: 25835992 [Abstract] [Full Text] [Related]
16. Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1. Moloughney JG, D Thomas J, Toney JH. FEMS Microbiol Lett; 2005 Feb 01; 243(1):65-71. PubMed ID: 15668002 [Abstract] [Full Text] [Related]
17. Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1. Arjomandi OK, Hussein WM, Vella P, Yusof Y, Sidjabat HE, Schenk G, McGeary RP. Eur J Med Chem; 2016 May 23; 114():318-27. PubMed ID: 27017264 [Abstract] [Full Text] [Related]
18. IMP-1 metallo-beta-lactamase-producing Pseudomonas aeruginosa in a university hospital in the People's Republic of China. Wang CX, Mi ZH. J Antimicrob Chemother; 2004 Dec 23; 54(6):1159-60. PubMed ID: 15537691 [No Abstract] [Full Text] [Related]
19. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)]. Hikida M, Terashima S, Sato Y, Okamoato R, Inoue M. Jpn J Antibiot; 2001 Nov 23; 54(11):571-9. PubMed ID: 11828603 [Abstract] [Full Text] [Related]
20. Contributions of IMP-10 metallo-beta-lactamase, the outer membrane barrier and the MexAB-OprM efflux system to high-level carbapenem resistance in Pseudomonas aeruginosa. Zhao WH, Hu Z, Chen G, Ito R, Hu ZQ. Chemotherapy; 2009 Nov 23; 55(3):168-74. PubMed ID: 19420932 [Abstract] [Full Text] [Related] Page: [Next] [New Search]